AI Stock Finder
Loading...
Skip to main content
Model output · Signal date Oct. 13, 2026

Daily Signals

2503 companies scored · Alpha · vs marketSwitch to Total · 30D 90D

Signal date 2026-10-13 Cut-offs from the 2026-10-13 run
Companies scored 2503 IC ≥ 0 · market cap ≥ $100M
Median forecast +0.26% Alpha · 90D
Long–short spread +3.94% Strong Buy minus Strong Sell, mean
Median IC 0.28 Spearman · 90D
Rating changes ▲ 47 ▼ 63 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · All

293 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1 LLYELI LILLY & Co Life Sciences 0.28 $1.1T Unlock rating and forecasts
2 JNJJOHNSON & JOHNSON Life Sciences 0.36 $635.6B Unlock rating and forecasts
3 ONCBeOne Medicines Ltd. Life Sciences 0.00 $517.9B Neutral +0.23% +0.26% ·
4 MRKMerck & Co., Inc. Life Sciences 0.02 $358.9B Unlock rating and forecasts
5 AMGNAMGEN INC Life Sciences 0.00 $223.2B Unlock rating and forecasts
6 GSKGSK plc Life Sciences 0.11 $202.5B Unlock rating and forecasts
7 GILDGILEAD SCIENCES, INC. Life Sciences 0.28 $186.5B Neutral +0.20% +0.38% ·
8 PFEPFIZER INC Life Sciences 0.37 $161.9B Unlock rating and forecasts
9 MRNAModerna, Inc. Life Sciences 0.71 $85.3B Unlock rating and forecasts
10 ARGXARGENX SE Life Sciences 0.07 $49.7B Neutral -0.07% -0.50% ·
11 TEVATEVA PHARMACEUTICAL INDUSTRIES LTD Life Sciences 0.03 $48.0B Neutral -0.22% +0.11% ·
12 RVMDRevolution Medicines, Inc. Life Sciences 0.47 $41.6B Unlock rating and forecasts
13 IDXXIDEXX LABORATORIES INC /DE Life Sciences 0.30 $41.3B Unlock rating and forecasts
14 BIIBBIOGEN INC. Life Sciences 0.28 $33.8B Unlock rating and forecasts
15 RPRXRoyalty Pharma plc Life Sciences 0.61 $33.2B Unlock rating and forecasts
16 ZTSZoetis Inc. Life Sciences 0.30 $31.3B Unlock rating and forecasts
17 ALNYALNYLAM PHARMACEUTICALS, INC. Life Sciences 0.44 $29.9B Unlock rating and forecasts
18 ZLABZai Lab Ltd Life Sciences 0.41 $27.6B Unlock rating and forecasts
19 ROIVRoivant Sciences Ltd. Life Sciences 0.41 $25.0B Neutral +0.23% +0.35% ·
20 UTHRUNITED THERAPEUTICS Corp Life Sciences 0.23 $23.6B Unlock rating and forecasts
21 BNTXBioNTech SE Life Sciences 0.00 $22.5B Neutral -0.10% -0.15% ·
22 INSMINSMED Inc Life Sciences 0.62 $21.5B Neutral -0.10% -0.35% ·
23 VTRSViatris Inc Life Sciences 0.36 $20.1B Neutral -0.08% -0.08% ·
24 EXELEXELIXIS, INC. Life Sciences 0.30 $14.7B Unlock rating and forecasts
25 NBIXNEUROCRINE BIOSCIENCES INC Life Sciences 0.13 $14.4B Unlock rating and forecasts
26 JAZZJazz Pharmaceuticals plc Life Sciences 0.67 $14.1B Neutral -0.11% -0.15% ·
27 SMMTSummit Therapeutics Inc. Life Sciences 0.33 $13.7B Neutral -0.11% -0.48% ·
28 CORTCORCEPT THERAPEUTICS INC Life Sciences 0.72 $12.7B Unlock rating and forecasts
29 HALOHALOZYME THERAPEUTICS, INC. Life Sciences 0.48 $12.6B Unlock rating and forecasts
30 KNSAKiniksa Pharmaceuticals International, plc Life Sciences 0.00 $12.4B Unlock rating and forecasts
31 TECHBIO-TECHNE Corp Life Sciences 0.31 $11.4B Unlock rating and forecasts
32 ELANElanco Animal Health Inc Life Sciences 0.23 $11.2B Neutral -0.11% +0.19% ·
33 BMRNBIOMARIN PHARMACEUTICAL INC Life Sciences 0.30 $10.5B Unlock rating and forecasts
34 KRYSKrystal Biotech, Inc. Life Sciences 0.00 $9.8B Unlock rating and forecasts
35 RGENREPLIGEN CORP Life Sciences 0.60 $9.7B Unlock rating and forecasts
36 TWSTTwist Bioscience Corp Life Sciences 0.60 $9.5B Unlock rating and forecasts
37 CYTKCYTOKINETICS INC Life Sciences 0.20 $8.6B Neutral +0.06% +0.16% ·
38 ARWRARROWHEAD PHARMACEUTICALS, INC. Life Sciences 0.21 $8.2B Unlock rating and forecasts
39 AXSMAxsome Therapeutics, Inc. Life Sciences 0.04 $8.2B Unlock rating and forecasts
40 SYRESpyre Therapeutics, Inc. Life Sciences 0.43 $7.6B Unlock rating and forecasts
41 IONSIONIS PHARMACEUTICALS INC Life Sciences 0.52 $7.3B Neutral +0.50% +0.25% ·
42 PRAXPraxis Precision Medicines, Inc. Life Sciences 0.30 $7.0B Neutral +0.23% +0.33% ·
43 ABVXAbivax S.A. Life Sciences 0.16 $6.8B Unlock rating and forecasts
44 ALKSAlkermes plc. Life Sciences 0.32 $6.7B Neutral +0.20% +0.25% ·
45 IOVAIOVANCE BIOTHERAPEUTICS, INC. Life Sciences 0.47 $6.6B Unlock rating and forecasts
46 LNTHLantheus Holdings, Inc. Life Sciences 0.39 $6.5B Unlock rating and forecasts
47 AMRXAmneal Pharmaceuticals, Inc. Life Sciences 0.02 $6.2B Neutral +0.17% +0.48% ·
48 KODKodiak Sciences Inc. Life Sciences 0.20 $6.2B Unlock rating and forecasts
49 IMVTImmunovant, Inc. Life Sciences 0.17 $6.1B Unlock rating and forecasts
50 BLRXBioLineRx Ltd. Life Sciences 0.00 $5.7B Neutral -0.11% -0.28% ·
1–50 of 293 Previous Next
Since the previous run

Rating changes

▲ 47▼ 63
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.